WuXi Advanced Therapies Capacity Update October 2024: Cell & Gene Therapy

In this presentation, WuXi Advanced Therapies provides an update on the capacity available at its 400,000+ square foot campus in Philadelphia, PA.

Capabilities include everything from early discovery services, to process development and scale-up, IND-enabling studies, clinical production, and commercial-scale manufacturing. This unique CTDMO not only provides development and manufacturing services to cell and gene therapy providers but also offers co-located bioanalytical testing services, thus streamlining timelines and de-risking products with complex and/or time-sensitive lot releases.